These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 18841282)

  • 21. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
    Motovska Z; Kala P
    Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atherothrombosis: a vanishing disease?
    Kesteloot H
    Acta Cardiol; 2009 Oct; 64(5):581-2. PubMed ID: 20058501
    [No Abstract]   [Full Text] [Related]  

  • 23. Cardiovascular ischemic event rates in outpatients with symptomatic atherothrombosis or risk factors in the united states: insights from the REACH Registry.
    Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Steg PG; Cannon CP; Brennan DM; Bhatt DL;
    Crit Pathw Cardiol; 2009 Jun; 8(2):91-7. PubMed ID: 19417637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Implications of the REACH registry for neurologists].
    Roquer J
    Med Clin (Barc); 2009 Sep; 132 Suppl 2():30-3. PubMed ID: 19631836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Learning lessons from REACH.
    Kassianos GC
    Int J Clin Pract; 2007 Nov; 61(11):1786-8. PubMed ID: 17935542
    [No Abstract]   [Full Text] [Related]  

  • 26. Ischaemic stroke patients with heterozygous factor V Leiden present with multiple brain infarctions and widespread atherothrombotic disease.
    Haapaniemi E; Helenius J; Jakovljević D; Soinne L; Syrjälä M; Kaste M; Lassila R; Tatlisumak T
    Thromb Haemost; 2009 Jan; 101(1):145-50. PubMed ID: 19132201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Venous and arterial thrombosis: different sides of the same coin?
    Franchini M; Mannucci PM
    Eur J Intern Med; 2008 Nov; 19(7):476-81. PubMed ID: 19013373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atherosclerosis in rheumatoid arthritis versus diabetes: a comparative study.
    Stamatelopoulos KS; Kitas GD; Papamichael CM; Chryssohoou E; Kyrkou K; Georgiopoulos G; Protogerou A; Panoulas VF; Sandoo A; Tentolouris N; Mavrikakis M; Sfikakis PP
    Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1702-8. PubMed ID: 19608975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pathology of atherosclerosis: plaque development and plaque responses to medical treatment.
    Insull W
    Am J Med; 2009 Jan; 122(1 Suppl):S3-S14. PubMed ID: 19110086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
    Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
    Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The CD40/CD40 ligand system: linking inflammation with atherothrombosis.
    Antoniades C; Bakogiannis C; Tousoulis D; Antonopoulos AS; Stefanadis C
    J Am Coll Cardiol; 2009 Aug; 54(8):669-77. PubMed ID: 19679244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does elevated C-reactive protein cause human atherothrombosis? Novel insights from genetics, intervention trials, and elsewhere.
    Nordestgaard BG
    Curr Opin Lipidol; 2009 Oct; 20(5):393-401. PubMed ID: 19667982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bottom blood pressure or bottom cardiovascular risk? How far can cardiovascular risk be reduced?
    Zanchetti A
    J Hypertens; 2009 Aug; 27(8):1509-20. PubMed ID: 19564795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dual antiplatelet treatment].
    Krupicka J
    Vnitr Lek; 2008 Oct; 54(10):985-91. PubMed ID: 19009766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study.
    McGill HC; McMahan CA; Gidding SS
    Circulation; 2008 Mar; 117(9):1216-27. PubMed ID: 18316498
    [No Abstract]   [Full Text] [Related]  

  • 36. Registries: they're not just for weddings anymore.
    Haley EC
    Neurology; 2008 Apr; 70(17):1508-9. PubMed ID: 18235077
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevention of cardiovascular disease in chronic kidney disease patients.
    Wanner C
    Semin Nephrol; 2009 Jan; 29(1):24-9. PubMed ID: 19121471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of and risk factors for childhood thrombosis: a single-center experience in Ankara, Turkey.
    Ozbek N; Alioglu B; Avci Z; Malbora B; Onay O; Ozyurek E; Atac FB
    Pediatr Hematol Oncol; 2009 Jan; 26(1):11-29. PubMed ID: 19206005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contributions of hyperhomocysteinemia to atherosclerosis: Causal relationship and potential mechanisms.
    Zhou J; Austin RC
    Biofactors; 2009; 35(2):120-9. PubMed ID: 19449439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
    Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM
    Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.